2023-08-09 06:11:40 ET
- LifeStance Health Group press release ( NASDAQ: LFST ): Q2 GAAP EPS of -$0.13 misses by $0.04 .
- Revenue of $259.6M (+23.9% Y/Y) beats by $4.39M .
- Total revenue grew 24% to $259.6 million. Strong revenue growth in the second quarter was driven primarily by net clinician growth and increased visit volumes.
- Total clinicians of 6,132 up 17%, a sequential net increase of 171 in the second quarter
- Raising revenue and Center Margin guidance: Now expecting full year 2023 revenue of $1.01 to $1.04 billion and Center Margin of $280 to $300 million; reaffirming full year 2023 Adjusted EBITDA guidance of $50 to $62 million
- For the third quarter of 2023, the Company expects total revenue of $250 to $260 million, Center Margin of $69 to $76 million, and Adjusted EBITDA of $11 to $17 million.
For further details see:
LifeStance Health Group GAAP EPS of -$0.13 misses by $0.04, revenue of $259.6M beats by $4.39M